151 related articles for article (PubMed ID: 30822414)
1. A Double-Blind, Randomized Trial Shows the Role of Zonal Priming and Direct Topical Application of Epigallocatechin-3-Gallate in the Modulation of Cutaneous Scarring in Human Skin.
Ud-Din S; Foden P; Mazhari M; Al-Habba S; Baguneid M; Bulfone-Paus S; McGeorge D; Bayat A
J Invest Dermatol; 2019 Aug; 139(8):1680-1690.e16. PubMed ID: 30822414
[TBL] [Abstract][Full Text] [Related]
2. Pre-Emptive Priming of Human Skin Improves Cutaneous Scarring and Is Superior to Immediate and Delayed Topical Anti-Scarring Treatment Post-Wounding: A Double-Blind Randomised Placebo-Controlled Clinical Trial.
Ud-Din S; Wilgus TA; McGeorge DD; Bayat A
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33917842
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects of epigallocatechin-3-gallate in human skin.
Domingo DS; Camouse MM; Hsia AH; Matsui M; Maes D; Ward NL; Cooper KD; Baron ED
Int J Clin Exp Pathol; 2010 Aug; 3(7):705-9. PubMed ID: 20830241
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Green Tea EGCG on Skin Wound Healing: A Comprehensive Review.
Xu FW; Lv YL; Zhong YF; Xue YN; Wang Y; Zhang LY; Hu X; Tan WQ
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684703
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
[TBL] [Abstract][Full Text] [Related]
6. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
[TBL] [Abstract][Full Text] [Related]
7. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.
Puri A; Nguyen HX; Banga AK
Int J Cosmet Sci; 2016 Oct; 38(5):512-23. PubMed ID: 27009797
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: results of two preclinical and phase II randomized control studies.
Kieran I; Knock A; Bush J; So K; Metcalfe A; Hobson R; Mason T; O'Kane S; Ferguson M
Wound Repair Regen; 2013; 21(3):428-36. PubMed ID: 23627460
[TBL] [Abstract][Full Text] [Related]
9. The effects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and α-lipoic acid.
Leu JG; Chen SA; Chen HM; Wu WM; Hung CF; Yao YD; Tu CS; Liang YJ
Nanomedicine; 2012 Jul; 8(5):767-75. PubMed ID: 21906577
[TBL] [Abstract][Full Text] [Related]
10. Acute Epigallocatechin 3 Gallate (EGCG) Supplementation Delays Gastric Emptying in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Fernandes RC; Araújo VA; Giglio BM; Marini ACB; Mota JF; Teixeira KS; Monteiro PA; Lira FS; Pimentel GD
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30127247
[No Abstract] [Full Text] [Related]
11. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
[TBL] [Abstract][Full Text] [Related]
12. EGCG inhibits hypertrophic scar formation in a rabbit ear model.
Song Y; Wang T; Yang L; Wu J; Chen L; Fan X; Zhang Z; Yang Q; Yu Z; Song B
J Cosmet Dermatol; 2023 Apr; 22(4):1382-1391. PubMed ID: 36606405
[TBL] [Abstract][Full Text] [Related]
13. Assessing the analgesic efficacy of oral epigallocatechin-3-gallate on epidural catheter analgesia in patients after surgical stabilisation of multiple rib fractures: a prospective double-blind, placebo-controlled clinical trial.
Zhang L; Liu W; You H; Chen Z; Xu L; He H
Pharm Biol; 2020 Dec; 58(1):741-744. PubMed ID: 32749173
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate augments therapeutic effects of mesenchymal stem cells in skin wound healing.
Li M; Xu J; Shi T; Yu H; Bi J; Chen G
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1115-1124. PubMed ID: 27557877
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M;
Lancet Neurol; 2016 Jul; 15(8):801-810. PubMed ID: 27302362
[TBL] [Abstract][Full Text] [Related]
17. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.
Katiyar SK; Matsui MS; Elmets CA; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):148-53. PubMed ID: 10048310
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress.
Katiyar SK; Afaq F; Perez A; Mukhtar H
Carcinogenesis; 2001 Feb; 22(2):287-94. PubMed ID: 11181450
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels.
Karmisholt KE; Wenande E; Thaysen-Petersen D; Philipsen PA; Paasch U; Haedersdal M
Lasers Surg Med; 2018 Jan; 50(1):28-36. PubMed ID: 28815643
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo evaluation of antifibrotic compounds in skin scarring: EGCG and silencing of PAI-1 independently inhibit growth and induce keloid shrinkage.
Syed F; Bagabir RA; Paus R; Bayat A
Lab Invest; 2013 Aug; 93(8):946-60. PubMed ID: 23835737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
